CL2021000660A1 - Compuestos quelantes de hierro para tratar condiciones estéticas de la piel - Google Patents
Compuestos quelantes de hierro para tratar condiciones estéticas de la pielInfo
- Publication number
- CL2021000660A1 CL2021000660A1 CL2021000660A CL2021000660A CL2021000660A1 CL 2021000660 A1 CL2021000660 A1 CL 2021000660A1 CL 2021000660 A CL2021000660 A CL 2021000660A CL 2021000660 A CL2021000660 A CL 2021000660A CL 2021000660 A1 CL2021000660 A1 CL 2021000660A1
- Authority
- CL
- Chile
- Prior art keywords
- skin conditions
- iron chelating
- aesthetic skin
- chelating compounds
- compounds
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0208—Tissues; Wipes; Patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0291—Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/11—Encapsulated compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/14—Liposomes; Vesicles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/496—Triazoles or their condensed derivatives, e.g. benzotriazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/007—Preparations for dry skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/92—Oral administration
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Dispersion Chemistry (AREA)
- Biochemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Se proporcionan en este documento compuestos quelantes de hierro, composiciones que contienen tales compuestos y métodos de utilización de los compuestos en el tratamiento de diversas condiciones de piel estéticas. Se pueden administrar las composiciones quelantes de hierro en forma tópica u oralmente. El tratamiento de las condiciones de piel estéticas incluye prevenir la aparición o retardar la progresión de condiciones de piel estéticas.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862734164P | 2018-09-20 | 2018-09-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2021000660A1 true CL2021000660A1 (es) | 2021-10-01 |
Family
ID=69887931
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2021000660A CL2021000660A1 (es) | 2018-09-20 | 2021-03-17 | Compuestos quelantes de hierro para tratar condiciones estéticas de la piel |
Country Status (12)
Country | Link |
---|---|
US (1) | US20210315789A1 (es) |
EP (1) | EP3852711A4 (es) |
JP (1) | JP2022501372A (es) |
KR (1) | KR20210065968A (es) |
CN (1) | CN113038920A (es) |
AU (1) | AU2019342136A1 (es) |
BR (1) | BR112021004905A2 (es) |
CA (1) | CA3113175A1 (es) |
CL (1) | CL2021000660A1 (es) |
IL (1) | IL281405A (es) |
SG (1) | SG11202102345SA (es) |
WO (1) | WO2020061474A1 (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020157064A1 (en) * | 2019-01-28 | 2020-08-06 | Tomorrowlabs Gmbh | New topical formulation for use in alopecia |
WO2023034701A1 (en) * | 2021-08-30 | 2023-03-09 | Tautona Group Ip Holding Company, L.L.C. | Hif-1 promoting compounds for treating autonomic skin dysfunction following spinal cord injury |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR7302M (es) * | 1966-03-04 | 1969-09-29 | ||
ATE176396T1 (de) * | 1987-10-22 | 1999-02-15 | Procter & Gamble | Chelatbildner enthaltende lichtschutzmittel |
FR2674748B1 (fr) * | 1991-04-03 | 1995-01-13 | Oreal | Utilisation de sphingolipides dans la preparation d'une composition cosmetique ou dermopharmaceutique protegeant la peau et les cheveux contre les effets nocifs de la pollution atmospherique. |
JPH10120557A (ja) * | 1996-10-16 | 1998-05-12 | Sekisui Chem Co Ltd | 創傷治療物質 |
JPH10182407A (ja) * | 1996-12-24 | 1998-07-07 | Kose Corp | 皮膚外用剤 |
JP2000136122A (ja) * | 1998-10-28 | 2000-05-16 | Kose Corp | 皮膚外用剤 |
FR2825920B1 (fr) * | 2001-06-15 | 2006-04-28 | Oreal | Desferal comme inhibiteur de no-synthase et utilisations |
AU2003282337B2 (en) * | 2002-11-07 | 2009-07-16 | Technion Research And Development Foundation Ltd. | Neuroprotective iron chelators and pharmaceutical compositions comprising them |
ITMI20022447A1 (it) * | 2002-11-19 | 2004-05-20 | Carlo Ghisalberti | Uso di piridinoni nel trattamento della purpura capillare ed affezioni cutanee correlate. |
JP4256389B2 (ja) * | 2003-11-17 | 2009-04-22 | セダーマ | テトラペプチドとトリペプチドの混合物を含む組成物 |
FR2869229B1 (fr) * | 2004-04-26 | 2006-08-25 | Sederma Soc Par Actions Simpli | Utilisation d'un inducteur des ugt par voie topique |
WO2005115379A2 (en) * | 2004-05-24 | 2005-12-08 | New York University | Method of treating or preventing pathologic effects of acute increases in hyperglycemia and/or acute increases of free fatty acid flux |
US7763289B2 (en) * | 2005-09-01 | 2010-07-27 | JoAl's Products, LLC | Topical turmeric skin care products |
ITMI20052262A1 (it) * | 2005-11-25 | 2007-05-26 | Fitologica Srl | Composizioni farmaceutiche e-o dermatocosmetiche topiche per il trattamento della alopecia androgenetica |
FR2900573B1 (fr) * | 2006-05-05 | 2014-05-16 | Sederma Sa | Nouvelles compositions cosmetiques renfermant au moins un peptide contenant au moins un cycle aromatique bloque |
US20100092546A1 (en) * | 2008-10-10 | 2010-04-15 | Gurtner Geoffrey C | Topical and Transdermal Delivery of HIF-1 Modulators to Prevent and Treat Chronic Wounds |
US10098857B2 (en) * | 2008-10-10 | 2018-10-16 | The Board Of Trustees Of The Leland Stanford Junior University | Topical and transdermal delivery of HIF-1 modulators to prevent and treat chronic wounds |
US20140370078A1 (en) * | 2013-06-12 | 2014-12-18 | The Board Of Trustees Of The Leland Stanford Junior University | Topical and Transdermal Delivery of HIF-1 Modulators to Prevent and Treat Chronic Wounds |
WO2011056667A2 (en) * | 2009-10-28 | 2011-05-12 | Guthery Eugene B | Rosacea topical skin treatment method and formulation |
US20100172865A1 (en) * | 2010-03-18 | 2010-07-08 | Shantha Totada R | Methods of enhancing hair growth |
US20120003300A1 (en) * | 2010-06-30 | 2012-01-05 | Pangaea Laboratories Ltd | Composition Comprising Vascular Endothelial Growth Factor (VEGF) for the Treatment of Hair Loss |
BR112015000621A2 (pt) * | 2012-07-12 | 2017-06-27 | Dsm Ip Assets Bv | composição cosmética compreendendo benzilsulfonil-d-ser-homophe-(4-amidino-benzilamida) e um poliálcool |
WO2015124581A1 (en) * | 2014-02-18 | 2015-08-27 | Medesis Pharma | Use of a reverse-micellar system for delivering chelators of radionuclides and metals |
US20160199437A1 (en) * | 2015-01-08 | 2016-07-14 | D. Travis Wilson | Therapeutic compositions including iron chelators and uses thereof |
JP2018517734A (ja) * | 2015-06-17 | 2018-07-05 | ディスパーソル テクノロジーズ リミテッド ライアビリティ カンパニー | デフェラシロクスの改善された製剤およびその作製方法 |
-
2019
- 2019-09-20 AU AU2019342136A patent/AU2019342136A1/en not_active Abandoned
- 2019-09-20 BR BR112021004905-3A patent/BR112021004905A2/pt not_active Application Discontinuation
- 2019-09-20 US US17/273,855 patent/US20210315789A1/en not_active Abandoned
- 2019-09-20 JP JP2021515532A patent/JP2022501372A/ja active Pending
- 2019-09-20 CN CN201980074073.6A patent/CN113038920A/zh active Pending
- 2019-09-20 WO PCT/US2019/052192 patent/WO2020061474A1/en active Application Filing
- 2019-09-20 CA CA3113175A patent/CA3113175A1/en active Pending
- 2019-09-20 SG SG11202102345SA patent/SG11202102345SA/en unknown
- 2019-09-20 EP EP19862327.4A patent/EP3852711A4/en not_active Withdrawn
- 2019-09-20 KR KR1020217011391A patent/KR20210065968A/ko active Search and Examination
-
2021
- 2021-03-10 IL IL281405A patent/IL281405A/en unknown
- 2021-03-17 CL CL2021000660A patent/CL2021000660A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
CA3113175A1 (en) | 2020-03-26 |
IL281405A (en) | 2021-04-29 |
AU2019342136A1 (en) | 2021-04-01 |
JP2022501372A (ja) | 2022-01-06 |
SG11202102345SA (en) | 2021-04-29 |
EP3852711A1 (en) | 2021-07-28 |
US20210315789A1 (en) | 2021-10-14 |
CN113038920A (zh) | 2021-06-25 |
BR112021004905A2 (pt) | 2021-06-01 |
KR20210065968A (ko) | 2021-06-04 |
EP3852711A4 (en) | 2022-06-08 |
WO2020061474A1 (en) | 2020-03-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP20005581A (es) | Compuestos y composiciones para tratar afecciones asociadas con la actividad nlrp | |
MX2018005600A (es) | Composiciones farmaceuticas y metodos para la inhibicion de indolamina 2,3-dioxigenasa e indicaciones para ello. | |
CL2020002019A1 (es) | Composiciones para modular la expresión de c9orf72. (divisional solicitud 201803582) | |
DOP2019000005A (es) | 3-metil pirazinas 2,5-disustituidas y 3-metil pirazinas 2,5,6-trisustituidas como inhibidores alostéricos de shp2 | |
CL2020002919A1 (es) | Inhibidores de mcl-1 | |
CL2019000821A1 (es) | Composiciones, métodos y usos para inhibir la actividad arginasa. (divisional solicitud 201801134) | |
CL2017001124A1 (es) | Agentes inmunomoduladores | |
MX2021001439A (es) | Composiciones y metodos para el tratamiento de la disfuncion de la glandula de meibomio. | |
CO2019001212A2 (es) | Composiciones y métodos de inhibición del masp-3 para el tratamiento de diversas enfermedades y trastornos | |
EP4272834A3 (en) | Therapeutic use of mitochondria and combined mitochondrial agents | |
NZ722326A (en) | Tricyclic compounds as anticancer agents | |
ECSP18024971A (es) | Terapia adjuntiva con 25-hidroxi vitamina d y artículos de la misma | |
EA201990951A1 (ru) | Комбинации, содержащие ssao/vap-1 ингибитор и sglt2-ингибитор, и их применение | |
NZ709635A (en) | Bcl-2bcl-xl inhibitors and therapeutic methods using the same | |
BR112015026297A2 (pt) | terapia combinada composta por um inibidor tor quinase e um composto de 5-quinazolinona substituído para o tratamento de câncer | |
CO2018005315A2 (es) | Moduladores de la interacción de sestrina-gator2 y sus usos | |
CL2019000190A1 (es) | Tratamiento y prevención de los trastornos del sueño. | |
MX2015016100A (es) | Inhibidores de criopirina para prevenir y tratar la inflamacion. | |
MX365366B (es) | Formulaciones tópicas y orales que comprenden taurina y magnesio para la prevención y el tratamiento del acné. | |
UY32359A (es) | Compuestos de plasmalogenos, composiciones farmaceuticas que los contienen y metodos para tratar enfermedades del envejecimiento | |
CL2021000660A1 (es) | Compuestos quelantes de hierro para tratar condiciones estéticas de la piel | |
BR112016007462A2 (pt) | fitonutrientes anti-inflamatórios para uso no tratamento ou prevenção de sinovite | |
MX2023010501A (es) | Profarmacos de dantroleno y metodos de su uso. | |
CL2017000845A1 (es) | Inhibidores de gingipaina de lisina | |
BR112018000217A2 (pt) | sistemas de distribuição de nanopartículas aperfeiçoados |